33 related articles for article (PubMed ID: 28855187)
1. Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
Hu S; Trieb M; Huang R; Tamalunas A; Keller P; Götz M; Waidelich R; Stief CG; Hennenberg M
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1219-1231. PubMed ID: 37658212
[TBL] [Abstract][Full Text] [Related]
2. Isoform-independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells.
Liu Y; Huang R; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
FASEB J; 2024 Apr; 38(7):e23604. PubMed ID: 38591106
[TBL] [Abstract][Full Text] [Related]
3. CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling.
Serwe G; Kachaner D; Gagnon J; Plutoni C; Lajoie D; Duramé E; Sahmi M; Garrido D; Lefrançois M; Arseneault G; Saba-El-Leil MK; Meloche S; Emery G; Therrien M
Nat Commun; 2023 Jun; 14(1):3560. PubMed ID: 37322019
[TBL] [Abstract][Full Text] [Related]
4. ARF6 mediates nephrin tyrosine phosphorylation-induced podocyte cellular dynamics.
Lin JS; Jeon JS; Fan Q; Wong HN; Palmer MB; Holzman LB
PLoS One; 2017; 12(9):e0184575. PubMed ID: 28880939
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.
Yu Q; Gratzke C; Wang Y; Herlemann A; Sterr CM; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Stief CG; Hennenberg M
Br J Pharmacol; 2018 Jun; 175(11):2077-2096. PubMed ID: 29574791
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells.
Huaman J; Naidoo M; Zang X; Ogunwobi OO
Cells; 2019 Jun; 8(6):. PubMed ID: 31226820
[TBL] [Abstract][Full Text] [Related]
7. Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer.
Miller DR; Tzeng CC; Farmer T; Keller ET; Caplan S; Chen YS; Chen YL; Lin MF
Cancer Lett; 2018 Nov; 436():96-108. PubMed ID: 30077739
[TBL] [Abstract][Full Text] [Related]
8. MRGBP promotes AR-mediated transactivation of KLK3 and TMPRSS2 via acetylation of histone H2A.Z in prostate cancer cells.
Ito S; Kayukawa N; Ueda T; Taniguchi H; Morioka Y; Hongo F; Ukimura O
Biochim Biophys Acta Gene Regul Mech; 2018 Aug; ():. PubMed ID: 30076933
[TBL] [Abstract][Full Text] [Related]
9. Altered small non-coding RNA expression profiles of extracellular vesicles in the prostatic fluid of patients with chronic pelvic pain syndrome.
Ouyang B; Han D; Guo Z; Deng J; Li W; Huang L; Liu J; Cai Z; Bian J; Huang S
Exp Ther Med; 2022 Jun; 23(6):382. PubMed ID: 35495611
[TBL] [Abstract][Full Text] [Related]
10. Does coupling to ADP ribosylation factor 6 explain differences between muscarinic and other receptors in interaction with β-adrenoceptor-mediated smooth muscle relaxation?
Erdogan BR; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):381-386. PubMed ID: 35175382
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729.
Huang R; Li B; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):471-485. PubMed ID: 35141760
[TBL] [Abstract][Full Text] [Related]
12. Regulation of smooth muscle contraction by monomeric non-RhoA GTPases.
Li B; Wang R; Wang Y; Stief CG; Hennenberg M
Br J Pharmacol; 2020 Sep; 177(17):3865-3877. PubMed ID: 32579705
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases.
Hennenberg M; Kuppermann P; Yu Q; Herlemann A; Tamalunas A; Wang Y; Rutz B; Ciotkowska A; Strittmatter F; Stief CG; Gratzke C
Front Physiol; 2018; 9():734. PubMed ID: 29962965
[No Abstract] [Full Text] [Related]
14. Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate.
Herlemann A; Keller P; Schott M; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Yu Q; Waidelich R; Strittmatter F; Stief CG; Gratzke C; Hennenberg M
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F47-F57. PubMed ID: 28855187
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005.
Hennenberg M; Schott M; Kan A; Keller P; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Strittmatter F; Herlemann A; Yu Q; Stief CG; Gratzke C
Prostate; 2016 Nov; 76(15):1364-74. PubMed ID: 27418235
[TBL] [Abstract][Full Text] [Related]
16. A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate.
Yu Q; Gratzke C; Wang R; Li B; Kuppermann P; Herlemann A; Tamalunas A; Wang Y; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
J Biol Chem; 2019 Aug; 294(32):12231-12249. PubMed ID: 31243101
[TBL] [Abstract][Full Text] [Related]
17. New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention.
Yu Q; Gratzke C; Wang Y; Wang X; Li B; Strittmatter F; Herlemann A; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
Prostate; 2019 May; 79(7):746-756. PubMed ID: 30811062
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
